BMSD : 10.65048
BMSD : 10.65048
https://doi.org/10.65048/ijbmr
Search
About Us
Authors
Reviewers
Editorial Board
Contact Us

International Journal of Biological and Medical Research (IJBMR)

Original Article
Year : 2026  |  Volume : 17  |  Issue : 2  |  Page : 8469-8474 Full Version
Knowledge and uptake of human papilloma virus (hpv) vaccine among female undergraduate medical students at the university of port harcourt, rivers state, nigeria.
Int J Biol Med Res. 2026; 17(2): 8469-8474  |  DOI: 10.65048/ijbmr.2026.17.2.8469.1026
a Enuagwuna, Fredrick Chuks, b Bethel, ChukwudinmaThankGod, b Chukwukeru Emmanuel Chinaedu, b Ogugua Chinedu
a Department of Preventive and Social Medicine, University of Port Harcourt, Choba, Rivers State/ Department of
Community Medicine, University of Port Harcourt Teaching Hospital
b College of Health Sciences, University of Port Harcourt, Choba, Rivers state
Correspondence Address :
Fredrick Chuks Enuagwuna,
Department of Preventive and Social Medicine,
University of Port Harcourt
Harcourt Teaching Hospital, Choba, Rivers State, Nigeria. E-mail: chuks_fredrick@uniport.edu.ng
Received: January 10, 2026 Accepted: February 25, 2026 Published: April 5, 2026

Abstract
Background: Human Papilloma Virus (HPV) is a common sexually transmitted infection responsible for several cancers, including cervical cancer, which ranks fourth among cancers in women worldwide and despite the availability of effective vaccines that can prevent over 90% of HPV-related malignancies, awareness and uptake remain low, especially in low- and middle-income countries like Nigeria. Female university students are a key target group for HPV vaccination as they fall within the recommended age range and can greatly benefit from improved awareness and preventive strategies. This study aimed to determine the level of knowledge of the HPV vaccine and uptake among female medical students at the University of Port Harcourt in Rivers State, Nigeria.
Methods: A descriptive cross-sectional study with two-stage sampling was employed. An online self-administered questionnaire was completed by 367 undergraduate female medical students at the institution. Data were analyzed using IBM statistical product and service solutions (SPSS) version 27. Data were summarized using means, frequency, proportions and regression analysis
Results: Of the 367 respondents, 37.6% had good knowledge of HPV infection and vaccine. Also, the uptake of the HPV vaccine among respondents was 8.2%, with only 20% of those vaccinated completing the full dose.
Conclusion: Knowledge of HPV infection and vaccine and uptake of the vaccine is unacceptably low. Without immediate and targeted interventions, the potential for HPV vaccination to reduce the burden of cervical cancer in Nigeria will remain largely unrealized.


Keywords
Human Papillomavirus, HPV, HPV vaccine, Knowledge, Uptake, Vaccine.

Introduction

With an estimated yearly mortality of roughly 350,000, the Human Papilloma Virus (HPV) is a common sexually transmitted infection (STI) and a major public health concern.[1] It kills a woman every two minutes and ranks fourth among cancers in women worldwide.[1, 2] Cervical, vulvar, anal, penile, and oropharyngeal cancers are among the several cancers that HPV causes.[2] About 75% of sexually active individuals will get HPV at some point in their lives.[3] At least 13 of the more than 100 HPV genotypes that are known to exist are responsible for genital, cervical, and pharyngeal malignancies.[3] The majority of HPV infections are asymptomatic or subclinical, which has aided in the virus's rapid transmission and spread.[3] According to estimates, in 2019, HPV caused 70,000 new cancer cases in men and 620,000 new cancer cases in women worldwide.4 HPV types 16 and 18 are known to cause 70% of cervical cancers, and while they can also cause cancer in other parts of the body (such as the vulva, vagina, penis, and anus), HPV types 6 and 11 causes 90% of cases of genital warts.3With around 660,000 new cases and 350,000 fatalities globally in 2022, cervical cancer was reported to be the fourth most common cause of cancer and cancer-related deaths in women.4More than 90% of women's HPV-related malignancies are cervical cancers.[4]

Sub-Saharan Africa had the greatest cervical HPV prevalence among women (24%), followed by Southeast Asia (14%), Eastern Europe (14%), and Latin America and the Caribbean (16%).4Because of geographical population heterogeneity and variations in diagnostic techniques, it has been difficult to estimate the prevalence of HPV infection in Nigeria.5Nevertheless, 32% was the estimated prevalence of HPV in Nigeria.[5] This indicates significant disparities caused by social and economic variables, lack of access to cervical screening and treatment facilities, and national HPV vaccination.[4]

One of the best methods for preventing HPV infections in women who have never had an HPV infection is the human papillomavirus vaccine.[3] More than 90% of HPV-related malignancies can be avoided by HPV vaccination.[3] Four preventative vaccinations that target high-risk HPV strains have been produced since the significance of HPV in the etiology of cervical cancer was identified.[6] The HPV 16 monovalent vaccine, HPV 16/18 bivalent vaccine, HPV 16/18/11 quadrivalent vaccine, and, more recently, HPV 16/18/11/31/33/45/52/58 nonavalent vaccine.[6] The bivalent and quadrivalent vaccines were approved for use in 2006 and 2007, and their positive benefits are clear from the fact that they have reduced the incidence of genital warts and high-grade cervical abnormalities worldwide.[6]

The World Health Organization (WHO) advises that girls aged 9–14 should be the primary target group for HPV vaccination, with females aged ≥ 15 years being the secondary target population.[3, 6] Despite this recommendation, vaccine uptake has varied, ranging from <5-86%.6Although there are many factors that contribute to vaccination uptake, awareness of HPV and the HPV vaccine has been found to be an important predictor of uptake.6According to research, there is now a low level of HPV awareness in the general community.6Although there is currently insufficient evidence to support this, it was hoped that the health promotion campaign that accompanied the launch of the vaccine would raise awareness of HPV.6Low HPV vaccine uptake in Nigeria may be the result of contradictory cultural attitudes and a lack of knowledge.[7]

One important group is university students, especially female undergraduates, who are usually in the age range that the HPV vaccine targets, frequently engage in sexual activity, and are available for educational interventions.Designing specialized strategies to increase coverage requires an understanding of their vaccination uptake and level of knowledge.

The aim of this study is to determine the level of knowledge of the HPV vaccine and uptake among female medical students at the University of Port Harcourt in Rivers State, Nigeria.

Materials and Method

Study Design

A descriptive, cross-sectional study design was employed for this study.

Study Setting

The study was carried out at the University of Port Harcourt, a tertiary institution located between latitude 4.09069N and longitude 6.9170E in Choba, Rivers, Nigeria.8 It is surrounded by the Aluu community, Alakiah community and Choba community.8The University of Port Harcourt has 3 campuses (Abuja, Delta, and Choba respectively),14 faculties and over 60 departments, with over 60,000 students.[8]

Study Participants

The participants for this study included female undergraduate medical students of the University of Port Harcourt.

Sample Size

In order to get the minimum sample size, a prevalence rate (p) of knowledge of HPV infection (33.6%) was estimated from a previous study that was carried out among female undergraduate students in Rivers State, Nigeria.[9] The minimum sample size was determined using Cochran’s formula10: n= (Z2P.q) / e2

Where n=sample size; e=error tolerance (level) or margin of error set at 0.05; p = sample proportion = 0.336; q=1-p =0.64; z-score value found on the z-score table (1.96).

The estimated sample size after adjusting for non-response using a rate of 10% was 367.

Sampling Techniques

This study employed a two-stage sampling technique to select participants from the College of Medicine at the University of Port Harcourt. The college of medicine at the University of Port Harcourt comprised 518 female undergraduate medical students out of a total of 1056 students across 100 to 600 levels.

In the first stage, a proportional allocation type of stratified random sampling technique was utilized to select the female students from each class. The female students were stratified by their respective classes, with the number of female students in each class being: 61 in 100 level, 85 in 200 level, 157 in 300 level, 64 in 400 level, 51 in 500 level, 43 in 600A level, and 57 in 600B level. To determine the sample size for each stratum, the formula: (number of female students in the class/ total number of female students) x sample size was applied. This calculation yielded the following expected sample sizes: 43 students from 100 level, 60 from 200 level, 111 from 300 level, 45 from 400 level, 36 from 500 level, 32 from 600A level, and 40 from 600B level.

The second stage involved the random selection of participants from each class. An online random number generator was used for this purpose. The serial numbers of all female undergraduate medical students in each class were obtained, and the range of serial numbers (from the lowest to highest) was inputted into the generator along with the expected sample size for each class. The generator then randomly selected the required number of serial numbers, and the students corresponding to these serial numbers, and the students corresponding to these serial numbers were chosen for the study. This process was repeated for each class ensuring a representative and random sample of female undergraduate medical students.

Study Instruments

The instrument was a semi-structured self-administered questionnaire. The questions to assess knowledge was derived from questions from previous related studies. The questionnaire was divided into three sub-sections with a brief introduction of the study and the principal investigators. The first section covered the sociodemographic information of the participants, the second section covered the level of knowledge of HPV infection and vaccination and the third section assessed the uptake of HPV vaccine among the respondents. The questionnaire was designed using google forms and distributed online. The aim of the research was explained to the students as well as instructions on how to fill the questionnaire. The link was then sent to each respondent and each respondent was followed up until all the responses were received.

Data Analysis

The data was cleaned by inspecting the questionnaires for completeness and analyzed using IBM Statistical Product for Service Solutions (SPSS) version 27.Numerical variables were summarized as means and standard deviations, while categorical data was summarized using proportions and percentages. In assessing the knowledge of human papillomavirus infection, participants with who score 50% and above will be regarded as having good knowledge while those who score below 50% will be regarded as having poor knowledge.

Study Duration

The study was carried out from July 2024 to December 2024

 

Results

Table 1.Socio-demographic Characteristics of the Respondents

The table shows the distribution of respondents based on their age classification. The ages of the respondents were between 15 and >30, with majority of the respondents falling into the age group of 21-25 years (49.6%). The table also showed that 99.2% of respondents were Christians, 0.3% were Muslims, 0.3% were polytheist, and 0.3% were neither Christians nor Muslims.The table also illustrates the ethnicity of the respondents, of which majority 37.1% (136) were Igbos, followed by the Ikwerre (13.1%), with the Isoko tribe having the least population (1.4%).The table also showed that majority of the respondents were single 99.7%, while only one respondent was married 0.3%.

Table 2. Knowledge of HPV infection and vaccination among female medical students of University of Port Harcourt

The table shows that 86.4% of the respondents has heard of Human Papillomavirus (HPV), with 55.1% of them getting the information from social media and 24.8% of them from lectures. 98.1% of the study participants know that the vaccine is for prevention. 54.5% of the respondents know that the mode of administration of the vaccine is via injection. 62.4% agreed that the recommended age for vaccination is 9-14 years. 53.1% of the study participants are unsure of the presence of the vaccine’s side effect The result shows that the level of good knowledge of HPV infection and vaccine is 37.6%.

The table shows that only 8.3% of the respondents had received the HPV vaccine, and 91.8% had not received the vaccine mostly due to not being sexually active (33.0%), lack of knowledge (24.5%), cost of vaccine (19.6%) or unavailability of the vaccine (16.9%).

The result shows that participants above 20 years of age were 2.273 times more likely to have a good knowledge of HPV vaccination than those below 20years of age and this finding was statistically significant. It also shows that for every one-year increase in age, there is an increase in knowledge of 0.821 units. The result also shows that at 95% of the time, the true value will fall within the range of 1.300-3.974, however there is a 5% chance that the true value will fall outside these range of values.

Discussion

The aim of this study is to determine the level of knowledge of the HPV vaccine and uptake among female medical students at the University of Port Harcourt in Rivers State, Nigeria.

This study found that about two-fifth of female undergraduate students at the University of Port Harcourt demonstrated good knowledge of HPV infection and its vaccine. Although this represents an improvement compared to a similar study among secondary school students in Port Harcourt, which reported a knowledge level below thirty-six percent [11], it remains suboptimal, particularly when considering the critical role of knowledge in vaccine acceptance and cervical cancer prevention.

When compared with healthcare workers, the knowledge level in our study was markedly lower than the sixty-nine-point five percent reported among midwives in the University of Port Harcourt Teaching Hospital[12] and the eighty-five-point five percent recorded among female healthcare professionals in Bayelsa State.[13] This disparity is expected, as health professionals are more likely to have better exposure to health-related information and targeted continuing medical education.

Our findings are consistent with studies conducted among similar populations. For instance, among seven hundred and eighty female undergraduates in Rivers State, the knowledge level for HPV infection wasthirty-three point six percent, and for HPV vaccine, twenty-six9, while studies in Kano State showed thirty-two percent [14], Benue State - thirty-nine point three percent [15], and North-Central Nigeria – thirty-one point eight percent16reported comparable outcomes. These findings suggest that knowledge of HPV infection and its vaccine remains generally low among young women in Nigerian tertiary institutions, despite differences in regional contexts.

Interestingly, the level of knowledge in our study was higher than that reported among undergraduates in Lagos State which showed three percent [17] and a Southwestern university – five point six percent [18] but lower than that observed among respondents in rural Ogun State which showed eighty-two percent [19] and among adolescent girls in Uganda which showed forty-nine point two percent [20] and Ethiopia – fifty eight point one percent. [21] The high levels of knowledge in some regions may reflect more effective public health awareness campaigns or better integration of HPV education into school curricula. Also, the level of knowledge in our study was higher than that reported among adult Saudi women which showed twenty-one point two [22].

Overall, this study highlights a persistent knowledge gap, even among university students who are expected to have greater access to information. This suggests inadequate dissemination of HPV-related information through mass media, school health programs, and healthcare professionals in Nigeria. Bridging this gap is crucial, as knowledge is a major determinant of vaccine acceptance and preventive health behaviors.

The uptake of the HPV vaccine among respondents was eight-point two percent, with only twenty percent of those vaccinated completing the full dose. This indicates a very low vaccine uptake, especially considering the high burden of HPV-related cervical cancer in Nigeria.

This uptake rate is higher than that reported among female undergraduates in Port Harcourt (which showed two point one percent [11], Ambrose Alli University – zero point four percent [23], and Lagos State – two point six percent. [17] It is also higher than that recorded among female healthcare professionals in Bayelsa State which showed five point one percent13 and medical and dental students in Benin City – three point seven percent. [24] However, it is lower than uptake levels in North-Central Nigeria which showed fifteen percent16 and among women of reproductive age in Benue State which showed thirteen point seven percent. [15]

Comparatively, uptake in our study is similar to that reported among secondary school students in Kano State which was eight percent14and adolescent girls in Kampala, Uganda – eight point six percent [20], but falls significantly short of the forty-five-point three percent reported among Ethiopian preparatory school students. [21] These variations suggest contextual influences such as awareness campaigns, accessibility of the vaccine, cultural beliefs, and cost factors, which differ between settings.

The low uptake in this study is not surprising considering the relatively poor knowledge levels identified. Multiple studies have demonstrated that awareness and understanding of HPV and its vaccine are strong predictors of vaccine acceptance. Additionally, barriers such as vaccine cost, availability, lack of government-supported programs, and misconceptions about HPV vaccination remain critical obstacles in Nigeria.

The findings from this study reveal a discrepancy between knowledge and practice, with knowledge levels being relatively higher than vaccine uptake, yet both remain far below optimal levels recommended for effective cervical cancer prevention. This suggests that knowledge alone is insufficient to drive uptake without addressing other barriers such as affordability, accessibility, and sociocultural perceptions of the vaccine.

To improve HPV vaccine uptake, multifaceted interventions are necessary, including: Strengthening school-based HPV education programs, subsidizing or providing free HPV vaccination through national immunization schedules, addressing vaccine hesitancy through targeted campaigns, and enhancing healthcare provider recommendation rates.

 

Limitation of the study

It is a descriptive cross-sectional study hence; it does not have temporal sequence. However, the large sample size of the respondents will provide a representative snapshot of the general population.

Implication of the findings of the study

The study’s findings on the low level of knowledge and uptake of HPV vaccine among female undergraduate medical students at the University of Port Harcourt have significant public health implications. The high prevalence of poor knowledge and low vaccine uptake (even among the medical population), suggests that a large proportion remains susceptible to HPV infection, which may contribute to future cases of cervical cancer. The population’s low vaccination rate indicates a missed opportunity for primary prevention, as university students fall within the optimal age range for vaccination. Furthermore, the misconceptions about HPV vaccination highlight the need for targeted health education programs, while cost and unavailability of the vaccine underscore socioeconomic barriers that must be addressed. Efforts such as collaborating with government health agencies and non-governmental organizations to offer subsidized or free HPV vaccines within the university health services can improve the vaccine accessibility and affordability. Additionally, a follow-up reminder system should be established to ensure that students who start the vaccination series complete all recommended doses.

Conclusions

This study revealed that knowledge and uptake of HPV vaccine among female medical undergraduate students at the University of Port Harcourt are low, with only 37.6% demonstrating good knowledge and a mere 8.2% having received the vaccine. The predominant barriers identified were misconceptions about the necessity of vaccination prior to sexual activity, lack of knowledge, cost and unavailability of the vaccine.

These findings highlight a critical gap in preventive health measures against HPV infection and its associated diseases, including cervical cancer, within this vulnerable population. Strengthening health education, improving access and affordability, and ensuring completion of the vaccine series are essential steps toward increasing vaccine coverage. Implementing these strategies within university settings could significantly contribute to achieving national and global HPV vaccination targets and ultimately reduce the burden of cervical cancer in Nigeria.

Acknowledgements

Our sincere gratitude goes to all the students who participated in this study.

Ethical clearance

Ethical clearance was obtained from the ethical committee of university of Port Harcourt following the laid down protocol. Informed consent was obtained from each of the respondents before proceeding with datacollection.

Authors’ contributions

All authors were involved in conceptualizing, planning and implementation of the study. All authors contributed to the interpretation of the results, read and approved the final manuscript.

Funding:

None




Conflicts of Interest:

None declared


References

[1].    AL Ghamdi NH. Knowledge of Human Papilloma Virus (HPV), HPV-vaccine and pap smear among adult Saudi women. Journal of Family medicine and primary care. 2022;(11)6:2989-2999. https://doi.org/10.4103/jfmpc.jfmpc_2094_21
[2].    Anni NS, Rehman N, Nyambi A, Musiwa A, Graham T, Dine RD et al. Knowledge, attitudes and practices towards Human Papilloma Virus and uptake of HPV vaccine: A protocol for a systematic review. PLoS one. 2024;19(11):e0313887. https://doi.org/10.1371/journal.pone.0313887
[3].    Lakneh EA, Mersha EA, Asresie MB, Belay HG. Knowledge, attitude and uptake of Human Papilloma virus vaccine and associated factors among female preparatory school students in Bahir Dar City, Amhara Region, Ethiopia. PLoS one. 2022;17(11):e0276465. https://doi.org/10.1371/journal.pone.0276465
[4].    World Health Organization. Human papillomavirus and cancer [online]. 2024 (cited 2025 August 30). Available from URL: https://www.who.int/news-room/fact-sheets/detail/human-papilloma-virus-and-cancer/
[5].    Anomo O, Bristow C, Mody N, Klausner JD. Estimated Prevalence of Human Papillomavirus among Nigerian women: A systematic review and meta-analysis. Afr J. Reprod. Health. 2022;26(6):89-96. 
[6].    Patel H, Jeve YB, Sherman SM, Moss EL. Knowledge of Human papillomavirus and the human papillomavirus in European adolescents: a systematic review. Transm Infect. 2016;92:474-479. Doi:10.1136/sextrans-2015-052341 
[7].    SABIN. Increasing HPV vaccine uptake: Overcoming Barriers for rural mothers in Nigeria [Online]. 2024 (cited 2025 August 30). Available from URL: https://www.sabin.org/resources/increasing-hpv-vaccine-uptaake-overcoming-barriers-for-rural-mothers-in-nigeria/
[8].    Wikipedia contributors. University of Port Harcourt [Internet]. 2022 [cited 2025, August 30]. Available from URL: https://en.wikipedia.org/wiki/University_of_Port_Harcourt
[9].    Ojimah C, Omosivie M. Awareness and uptake of human papillomavirus vaccines among female undergraduate students: Implications for cervical cancer prevention in South-South, Nigeria. Port Harcourt Medical Journal. 2017;11(3):134-140. https://doi.org/10.60787/phmj.v11i3.126
[10].    Uakarn C, Chaokromthong K, Sintao N. Sample Size Estimation using Yamane and Cochran and Krejcieand Morgan and Green Formulas and Cohen Statistical Power Analysis by G*Power and Comparisons. Apheit int’l journal. December 20, 2021;10(2):76-88
[11].    Oboro IL, Ogaji DS. Knowledge and Uptake of Human Papillomavirus Vaccine Among Female Adolescents in Port Harcourt: A call for Urgent Intervention. International STD Research and Reviews. 2023;12(1):1-11. https://doi.org/10.9734/ISRR/2023/v12i1152
[12].    Ikukaiwe JN, Gbobbo J. Knowledge of Human Papilloma Virus Infections and Vaccination Among Midwives in University of Port Harcourt, Rivers State, Nigeria. International Journal of Research and Scientific Innovation. 2025;12(15):812-824.
[13].    Okpara AL, Mariere UI, Nwankwo PO, Wagio TJ, Rotifa SU, Gordon A, et al. Knowledge, Perception and Uptake of Human Papilloma Virus (HPV) Vaccination Among Female Healthcare Professionals in a state in Southern Nigeria. International Journal of Research and Reports in Gynaecology. 2025;8(1):154-165. https://doi.org/10.9734/ijrrgy/2025/v8i1127
[14].    Rabiu I, Yahuza Z. Knowledge and attitude towards human papilloma virus infection, vaccines and cervical cancer prevention among school students in Kano, Nigeria. Advances in Virology. 2023;1(1):2803420. https://doi.org/10.1155/2023/2803420
[15].    Akinnibosun O, Abakpa OG, Ujoh AJ, Oche DA, Zakari S, Yandev D. Knowledge, Attitudes and Practices among women of reproductive age on human papilloma virus infection, cervical cancer and vaccination in Otukpo, Nigeria. Ethiopian Journal of Health Sciences. 2024;34(1). doi:10.4314/ejhs.v34:1.3 
[16].    Onasoga OA, Dosumu TO, Folarin AO, Shittu BM. Knowledge and uptake of human papilloma virus vaccine among female undergraduate students in North-Central Nigeria: A cross-sectional study. Int J Community Based Nurs Midwifery. 2025;13(2):126-137. doi:10.30476/ijcbnm.2025.102762.2509
[17].    Oluwole EO, Idowu OM, Adejimi AA, Balogun MR, Osanyinn GE. Knowledge, attitude and uptake of human papilloma virus vaccination among female undergraduates in Lagos State, Nigeria. Journal of family medicine and primary care. 2019;8(11):3627-3633. doi:10.4103/jfmpc.jfmpc_520_19 
[18].    Lawal AF, Issa AA, Ibrahim OR, Ogunkunle TO, Omokanye KO, Saka MJ. Knowledge of human papillomavirus vaccine among undergraduate students at a Nigerian university. Discov Public Health. 2025;22(1):260. https://doi.org/10.1186/s12982-025-00655-x
[19].    Olubodun T, Ogunsola EA, Coker MO, Olayinka SA, Elegbede WA, Ojediran JO, et al. HPV Vaccine Knowledge, attitude, and programme satisfaction among parents and caregivers of vaccine recipients in Ogun State, Nigeria. Reproductive Health. 2024;21(1):179
[20].    Bitanho GK, Tuhebwe D, Tigaiza A, Nalugya A, Ssekamata T, Kiwanuka SN. Knowledge, perceptions and uptake of human papilloma virus vaccine among adolescent girls in Kampala, Uganda; a mixed-methods school-based study. BMC Pediatr. 2023;23(1):368. doi:10.1186/s12887-023-04174-2
[21].    Lakneh EA, Mersha EA, Asresie MB, Belay HG. Knowledge, attitude and uptake of human papilloma virus vaccine and associated factors among female preparatory school students in Bahir Dar city, Amhra region, Ethiopia. PLoS one. 2022;17(11):e0276465. https://doi.org/10.1371/journal
[22].    Al Ghamdi NH. Knowledge of human papilloma virus (HPV), HPV-vaccine and papsmear among adult Saudi women. J Family Med Priim Care. 2022;11(6):2989-2999. doi.10.4103/jfmpc.jfmpc-2094-21 
[23].    Isara AR, Osayi N. Knowledge of Human papillomavirus and uptake of its vaccine among female undergraduate students of Ambrose Alli University, Ekpoma, Nigeria. Journal of Community Medicine and Primary Healthcare. 2021;33(1):64-75. doi:10.4314/jcmphc.v33i1.6 
[24].    Onowhapor AO, Omuemu VO, Osagie OL, Odili CG. Human Papilloma virus vaccination: Knowledge, attitude and uptake among female medical and dental students in a tertiary institution in Benin city, Nigeria. Journal of community medicine and primary healthcare. 2016;28(2):101-108.
 


IJBMR -ISSN: 0976:6685. ©Copyright 2026 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Published by BioMedSciDirect Publications